Category: News

News
sanderpoelert

Terumo Acquires Quirem Medical to Enhance Its Interventional Oncology Field

TOKYO and DEVENTER, Netherlands, July 15, 2020 — Terumo Corporation (TSE: 4543) today announced it has completed the acquisition of Quirem Medical B.V., a Netherlands-based healthcare startup specializing in the development of next-generation microspheres for Selective Internal Radiation Therapy (SIRT), a treatment for liver tumors. Under the terms of the agreement, Terumo acquired 80.1%

Read More »
News
admin

Lancet Oncology reports safety and efficacy of Holmium-166 SIRT after PRRT

Terumo Europe N.V. and Quirem Medical B.V are proud to share the latest key publication regarding holmium-166 (QuiremSpheres®) Selective Internal Radiation Therapy (SIRT). On 27 February 2020, the UMC Utrecht published their latest results in the Lancet Oncology Journal from the non-randomized HEPAR PLuS study. The study enrolled neuroendocrine tumor

Read More »

Dose-response relation confirmed for Holmium-166 (QuiremSpheres®) SIRT

Quirem Medical is pleased to share that yet another Holmium-166 (QuiremSpheres®) related scientific article has been published, after recently having reported on the publication of Smits et al. on the superior predictive value of 166Ho-Scout (QuiremScout®) compared to 99mTc-MAA as a SIRT work-up. This new, corner-stone publication by Bastiaannet et

Read More »

Radboud university medical center and Quirem Medical sign cooperation agreement

Radboud university medical center and Quirem Medical today signed an agreement for joint research. The agreement includes several existing and future projects based on small radioactive spheres (holmium-166 microspheres). Enhanced cooperation should improve the treatment of cancer patients and stimulate research into new applications. “Radboud university medical center strives for

Read More »

QuiremScout® superior in predicting intrahepatic dose distribution

In their study, Smits et al. showed that QuiremScout® is a superior predictor of  intrahepatic dose distribution compared to Tech-99m-MAA. The results of their study were published online on the 9th of August 2019 in the European Journal of Nuclear Medicine and Molecular Imaging. With individualized treatment planning becoming increasingly

Read More »